A Single and Multiple Doses Safety, Tolerability, Pharmacokinetics and Food Effect Study of KVD824 in Healthy Volunteers
Status:
Completed
Trial end date:
2019-06-21
Target enrollment:
Participant gender:
Summary
This is a 3 part phase 1, randomized, double-blind, placebo-controlled, study of the safety,
tolerability, and pharmacokinetics of KVD824 following administration of single and multiple
ascending oral doses; followed by a crossover food effect sub-study in healthy male
volunteers.